Chronic Obstructive Pulmonary Disease - a Disease Out of Control 1

Abstract

Get full access to this article

View all access options for this article.

References

Badham

. Observations on the inflammatory affections of the mucous membranes of the bronchi. London: Callow, 1808.

Laennec

RTH

. A treatise on the diseases of the chest and on mediate auscultation. Translated by John Forbes. 2nd ed. London: Underwood, 1827.

Tanner

. The Practice of Medicine. 6th Edition. Vol 1, Part V, section X. Bronchitis. London: Renshaw, 1869; 54–61.

Ciba Guest Symposium. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax 1959; 14:286–99.

American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 139:225–44.

European Respiratory Society Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398–420.

American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77–120.

Sandford

Weir

Paré

. Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1380–91.

Doll

Peto

Wheatley

. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994; 9:901–11.

10.

Christie

. Emphysema of the lungs. BMJ 1944; 1:105–8, 143–6.

11.

Marks

Burney

PGJ

. Diseases of the respiratory system. Chapter 20.In: Charlton

Murphy

, eds. Health of adult Britain: 1841 to 1994 Part II. London: HMSO, 1997; 93–113.

12.

Barker

Godfrey

Fall

. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991; 303:671–5.

13.

Shahar

Folsom

Melnick

. Dietary R-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Eng J Med 1994; 331:228–33.

14.

Britton

Pavord

Richards

. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 1995; 151:1383–7.

15.

Jarvis

. Smoking cessation. Eur Respir Rev 1997; 7(45):230–4.

16.

Becklake

. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140:S85–9.

17.

Fletcher

Peto

Tinker

Speizer

. The natural history of chronic bronchitis and emphysema. Oxford: OUP, 1976.

18.

Fletcher

Peto

. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645–8.

19.

Burrows

Knudson

Cline

Lebowitz

. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977; 115:195–205.

20.

Orie

NGM

Sluiter

de Vries

. The host factor in bronchitis. In: Bronchitis. An international symposium, 27–29 April 1960, University of Gronigen. Assen: Royal Van Gorcum, 1961; 43–59.

21.

Peto

Speizer

Cochrane

. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128:491–500.

22.

Ebi-Kryston

. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 1988; 41:251–60.

23.

Vestbø

Prescott

Lange

, and The Copenhagen Heart Study Group. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med 1996; 153:1530–5.

24.

Taylor

Joyce

Gross

. Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers. Thorax 1985; 40:9–16.

25.

Tashkin

Altose

Connett

. for the Lung Health Study Research Group. Airway responsiveness to inhaled methacholine in smokers with early chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145:301–10.

26.

Tashkin

Altose

Connett

. for the Lung Health Study Research Group. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:1802–11.

27.

Gillooly

Lamb

. Microscopic emphysema in relation to age and smoking habit. Thorax 1993; 48:39–43.

28.

Hogg

Wright

Wiggs

. Lung structure and function in cigarette smokers. Thorax 1994; 49:473–8.

29.

Thurlbeck

Hogg

. Lung structure and function in cigarette smokers. Thorax 1994; 49:1276–7.

30.

Anthonisen

Connett

Kiley

. Effects of smoking intervention and the use of an inhaled anti-cholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272:1497–505.

31.

Smoking Cessation Clinical Practice Guideline: Consensus Statement. JAMA 1996; 275:1270–80.

32.

Hurt

Sachs

DPL

Glover

. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195–202.

33.

Callaghan

Dittus

Katz

. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991; 114:216–23.

34.

Albert

Martin

Lewis

. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980; 92:753–8.

35.

Thompson

Nielson

Carvalho

. Controlled trial of oral prednisolone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154:407–12.

36.

Van Schayck

van Grunsven

Dekhuijzen

PNR

. Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur Respir J 1996; 9:1969–72.

37.

Dompeling

van Schayck

van Grunsven

. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med 1993; 118:770–8.

38.

Saetta

. Airway pathology of COPD compared with asthma. Eur Respir Rev 1997; 7(45):211–5.

39.

Jeffery

. Bronchial biopsies and airway inflammation. Eur Respir J 1996; 9:1583–7.

40.

Hutchison

DCS

Hughes

. Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved? Eur Respir J 1997; 10:2191–3.

41.

British Thoracic Society. Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(suppl 5):S1–28.

42.

Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic lung disease: a clinical trial. Ann Intern Med 1980; 93:391–8.

43.

Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; i:681–6.

44.

Ström

. Survival of patients with chronic obstructive pulmonary disease receiving long-term oxygen therapy. Am Rev Respir Dis 1993; 147:585–91.

45.

Górecka

Gorzelak

Sliwinski

. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997; 52:674–9.

46.

Hosenpud

Bennett

Keck

. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24–7.

47.

Gaissert

Trulock

Cooper

. Comparison of early results after volume reduction or lung transplantation for COPD. J Thorac Cardiovasc Surg 1996; 111:296–307.

48.

Massaro

G de C

Massaro

. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nature Medicine 1997; 3:675–7.

49.

Mannino

Brown

Giovino

. Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156:814–8.

50.

Nicolaides-Bouman

Wald

Forey

Lee

. International Smoking Statistics. Oxford: Oxford University Press, 1993.

51.

Murray

CJL

Lopez

. Evidence-based health policy - Lessons from the Global Burden of Disease Study. Science 1996; 274:740–3.

52.

Murray

CJL

Lopez

. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349:1498–504.

53.

Wald

Hackshaw

. Cigarette smoking: an epidemiological overview. Br Med Bull 1996; 52:3–11.